Day: February 13, 2025

Codere Online Granted Listing Extension by Nasdaq and to Release Q4-24 Earnings on February 20th

Written by Customer Service on February 13, 2025. Posted in Public Companies.

Luxembourg, Grand Duchy of Luxembourg, February 13, 2025 (GLOBE NEWSWIRE) – Codere Online Luxembourg, S.A. (Nasdaq: CDRO / CDROW) (the “Company” or “Codere Online”), a leading online gaming operator in Spain and Latin America, today announced that, by letter received on February 12, 2025, the Nasdaq Hearings Panel (the “Panel”) of The Nasdaq Stock Market LLC (“Nasdaq”) has determined to grant the Company’s request to continue its listing on Nasdaq, subject to the Company filing its annual report on Form 20-F for the year ended December 31, 2023 (the “2023 Annual Report”) on or before May 12, 2025. The Panel’s determination follows a hearing on January 16, 2025, at which the Panel considered the Company’s plan to regain compliance with Listing Rule 5250(c)(1) (the “Rule”). The Company has and continues to...

FRANKSPEECH NETWORK, INC further known as Mike Lindell Media Corp. (OTC Pink “FSBN”) Announces the Appointment of Former MLB Player, Rob Rogers to its Board of Directors.

Written by Customer Service on February 13, 2025. Posted in Public Companies.

Energy Shot Mogul Rob Rogers joins Mike Lindell, Rudy Giuliani and the Board of Directors at FrankSpeech Network, Inc., further known as Mike Lindell Media Corp. Salt Lake City, Utah, Feb. 13, 2025 (GLOBE NEWSWIRE) — FrankSpeech Network, Inc (“FSBN”), which is currently being rebranded as Mike Lindell Media Corp., today announced the addition of Rob Rogers to its Board of Directors. Rob Rogers, a serial entrepreneur, and former baseball player with the Cleveland Indians, has accepted a board position with FrankSpeech Network. Rob invented and patented the amazing ingredient goBHB through his company Ketone Labs. goBHB is the Future of Nutrition. Ketone Labs is on a mission to impact the Health of the World. To date they have sold over 300 million doses of goBHB, and they are just starting. Rob is all about giving back, he said,...

Biodexa Pharmaceuticals PLC to Present at the Emerging Growth Conference on February 19, 2025

Written by Customer Service on February 13, 2025. Posted in Public Companies.

February 13, 2025 Biodexa Pharmaceuticals PLC to Present at the Emerging Growth Conference on February 19, 2025 Biodexa Pharmaceuticals PLC invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 19, 2025. The live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO / CFO, Stephen Stamp in real time. Mr Stamp will make a presentation...

Barfresh to Host Business Update Call on February 27, 2025

Written by Customer Service on February 13, 2025. Posted in Public Companies.

LOS ANGELES, Feb. 13, 2025 (GLOBE NEWSWIRE) — Barfresh Food Group Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that it will host a business update call on Thursday, February 27, 2025 at 1:30 pm Pacific Time (4:30 pm Eastern Time). Listeners can dial (877) 407-4018 in North America, and international listeners can dial (201) 689-8471. A telephonic playback will be available approximately two hours after the call concludes and will be available through Thursday, March 13, 2025. Listeners in North America can dial (844) 512-2921, and international listeners can dial (412) 317-6671. Passcode is 13750486. Interested parties may also listen to a simultaneous webcast of the conference call by logging onto the company’s website at www.barfresh.com...

Freddie Mac Announces Fourth Quarter and Full-Year Financial Results

Written by Customer Service on February 13, 2025. Posted in Earnings Releases And Operating Results.

MCLEAN, Va., Feb. 13, 2025 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its Fourth Quarter and Full-Year 2024 financial results and filed its Annual Report on Form 10-K with the U.S. Securities and Exchange Commission. The company’s Form 10-K and earnings press release, along with the Fourth Quarter 2024 financial results supplement are available now on the Investor Relations page of the company’s website. The company will hold a call at 9 a.m. Eastern Time (ET) today, February 13, 2025, to share its results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, and affordability in the housing market throughout all economic...

Stryker to participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day

Written by Customer Service on February 13, 2025. Posted in Public Companies.

Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) will participate in Citi’s 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York. Stryker’s management will represent the Company in a presentation scheduled for 12:15 p.m. Eastern Time. A simultaneous webcast and replay of the Company’s presentation will be available on Stryker’s website at www.stryker.com. The webcast will be archived on the Investor Relations page of this site. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around...

Foremost Clean Energy to Attend Prospectors & Developers Association of Canada (PDAC) 2025 Convention

Written by Customer Service on February 13, 2025. Posted in Public Companies.

VANCOUVER, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) — Foremost Clean Energy Ltd. (NASDAQ: FMST) (CSE: FAT) (“Foremost” or the “Company”), a rapidly growing North American American uranium and lithium exploration company is pleased to announce that it is participating for the first two days in the upcoming Prospectors & Developers Association of Canada (PDAC) 2024 Convention – the world’s premier mineral exploration & mining convention – taking place March 02-05, 2025 at the Metro Toronto Convention Centre (MTCC) in Toronto, Canada. PDAC 2025 is the world’s premier mineral exploration and mining convention and the leading event for people, companies and organizations connected to mineral exploration. The annual award winning PDAC Convention in Toronto, Canada brings together over 27,000 attendees from over 135+...

Rezolve Ai to Acquire GroupBy Strengthening Market Leadership in Commerce Site Search and Digital Engagement

Written by Customer Service on February 13, 2025. Posted in Mergers And Acquisitions.

Strategic acquisition expands Rezolve Ai’s capabilities in Commerce Site Search, unlocking synergies with enterprise clients and global infrastructure NEW YORK, Feb. 13, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), a global leader in AI-driven commerce solutions, today announced that it has entered into a purchase agreement to acquire GroupBy Inc. (www.groupbyinc.com), a leader in enterprise-grade site search, product discovery, and merchandising solutions. The acquisition’s completion is subject to the fulfilment or waiver of standard closing conditions. This bold move will reinforce Rezolve Ai’s position as a leader in transforming digital commerce experiences. Powering the Future of Digital CommerceGroupBy has spent over 12 years optimizing product discovery for some of the world’s most recognized brands, including...

Sonnet BioTherapeutics Provides Fiscal Year 2025 First Quarter Business and Earnings Update

Written by Customer Service on February 13, 2025. Posted in Earnings Releases And Operating Results.

Completion of SON-1010 (IL12–FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of dosing was seen in 48% evaluable monotherapy patients, and one patient dosed at the MTD, resulting in a partial response (PR) Continued progress with clinical trials evaluating SON-1010 in combination with Atezolizumab, for Platinum-Resistant Ovarian Cancer (PROC) and in combination with trabectedin in certain advanced soft-tissue sarcomas (STS) SON-1210 bifunctional Interleukins 12 and 15, on FHAB platform, in combination with chemotherapy for the treatment of advanced solid tumors and metastatic pancreatic cancer expected to initiate clinical trial with first patient dosed in H1 calendar year 2025 Company has initiated a licensing partnership in India for SON-080 in October 2024 and reorganizes...

Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update

Written by Customer Service on February 13, 2025. Posted in Earnings Releases And Operating Results.

Announced Phase 3 STRIVE-ON Safety Trial Met Primary Endpoint and Provided Clinical Benefit Compared to Orally Administered Nimodipine; New Drug Application (NDA) Submission Anticipated First Half of Calendar 2025 Secured Private Placement Financing of $15 Million in Upfront Gross Proceeds with the Potential to Receive up to an Additional $15 Million in Potential Warrant Exercise Proceeds for an Aggregate of Up to Approximately $30 Million in Potential Total Gross Proceeds PRINCETON, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) — Grace Therapeutics, Inc. (Nasdaq: GRCE) formerly Acasti Pharma Inc. (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed for IV infusion to address significant unmet medical needs in aneurysmal subarachnoid...

Day: February 13, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals